NCT05349435View on ClinicalTrials.gov

A Healthy Volunteer Study to Compare Fezagepras (PBI-4050) With Sodium Phenylbutyrate

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 13, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Hyperammonemia
Interventions
DRUG

Fezagepras

Investigational drug

DRUG

Sodium phenylbutyrate

Investigational drug

Trial Locations (1)

BT9 6AD

Celerion, Belfast

Sponsors
All Listed Sponsors
lead

Liminal BioSciences Ltd.

INDUSTRY